CKD Bio Corp operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CKD Bio Corp with three other
companies in this sector in South Korea:
Hwail Pharmaceutical Company Limited
sales of 111.52 billion Korean Won [US$99.81 million]
(139.44 billion Korean Won [US$124.80 million]
Samil Pharmaceutical Co., Ltd.
(96.76 billion Korean Won [US$86.60 million]
CKD Bio Corp reported sales of 113.01 billion Korean Won (US$101.15 million)
December of 2016.
increase of 5.9%
versus 2015, when the company's sales were 106.69 billion Korean Won.
This was the third consecutive year of growth at CKD Bio Corp.
The sales level in 2016 was fairly close to the level five years ago: in 2011, CKD Bio Corp had sales
of 110.53 billion Korean Won.